These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 29029037)

  • 1. Functional variants in the low-density lipoprotein receptor gene are associated with clear cell renal cell carcinoma susceptibility.
    Zhang GM; Wang MY; Liu YN; Zhu Y; Wan FN; Wei QY; Ye DW
    Carcinogenesis; 2017 Dec; 38(12):1241-1248. PubMed ID: 29029037
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Methylenetetrahydrofolate reductase (MTHFR) gene C677T, A1298C and G1793A polymorphisms: association with risk for clear cell renal cell carcinoma and tumour behaviour in men.
    Safarinejad MR; Shafiei N; Safarinejad S
    Clin Oncol (R Coll Radiol); 2012 May; 24(4):269-81. PubMed ID: 21489764
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Variants in angiogenesis-related genes and the risk of clear cell renal cell carcinoma.
    Qin C; Chen J; Li J; Ju X; Zhang S; Cao Q; Han Z; Li P; Shao P; Wang M; Zhang Z; Gu M; Zhang W; Yin C
    Mutagenesis; 2014 Nov; 29(6):419-25. PubMed ID: 25239121
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of a functional polymorphism in the pre-miR-146a gene on the risk and prognosis of renal cell carcinoma.
    Huang Z; Lu Z; Tian J; Wang G; Gao Z
    Mol Med Rep; 2015 Nov; 12(5):6997-7004. PubMed ID: 26323945
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MDM2 SNP309 polymorphism as risk factor for susceptibility and poor prognosis in renal cell carcinoma.
    Hirata H; Hinoda Y; Kikuno N; Kawamoto K; Suehiro Y; Tanaka Y; Dahiya R
    Clin Cancer Res; 2007 Jul; 13(14):4123-9. PubMed ID: 17634539
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of 3' nearby gene BTLA polymorphisms with the risk of renal cell carcinoma in the Polish population.
    Partyka A; Tupikowski K; Kolodziej A; Zdrojowy R; Halon A; Malkiewicz B; Dembowski J; Frydecka I; Karabon L
    Urol Oncol; 2016 Sep; 34(9):419.e13-9. PubMed ID: 27234378
    [TBL] [Abstract][Full Text] [Related]  

  • 7. LDLR promotes growth and invasion in renal cell carcinoma and activates the EGFR pathway.
    Zhang GM; Chen W; Yao Y; Luo L; Sun LJ
    Neoplasma; 2022 Jan; 69(1):113-122. PubMed ID: 34846158
    [TBL] [Abstract][Full Text] [Related]  

  • 8. miR149 rs71428439 polymorphism and risk of clear cell renal cell carcinoma: a case-control study.
    Wang Z; Wei M; Ren Y; Liu H; Wang M; Shi K; Jiang H
    Tumour Biol; 2014 Dec; 35(12):12127-30. PubMed ID: 25213695
    [TBL] [Abstract][Full Text] [Related]  

  • 9. XRCC3 Thr241Met and XPD Lys751Gln gene polymorphisms and risk of clear cell renal cell carcinoma.
    Loghin A; Bănescu C; Nechifor-Boila A; Chibelean C; Orsolya M; Nechifor-Boila A; Tripon F; Voidazan S; Borda A
    Cancer Biomark; 2016; 16(2):211-7. PubMed ID: 26682510
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk of renal cell carcinoma and polymorphism in phase I xenobiotic metabolizing CYP1A1 and CYP2D6 enzymes.
    Ahmad ST; Arjumand W; Seth A; Nafees S; Rashid S; Ali N; Hamiza OO; Sultana S
    Urol Oncol; 2013 Oct; 31(7):1350-7. PubMed ID: 22281432
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combined effects of DNA methyltransferase 1 and 3A polymorphisms and urinary total arsenic levels on the risk for clear cell renal cell carcinoma.
    Yang SM; Huang CY; Shiue HS; Pu YS; Hsieh YH; Chen WJ; Lin YC; Hsueh YM
    Toxicol Appl Pharmacol; 2016 Aug; 305():103-110. PubMed ID: 27292127
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A novel functional polymorphism of GSTM3 reduces clear cell renal cell carcinoma risk through enhancing its expression by interfering miR-556 binding.
    Wang Y; Yang ZY; Chen YH; Li F; Shen H; Yu Y; Huang HY; Shen ZY
    J Cell Mol Med; 2018 Jun; 22(6):3005-3015. PubMed ID: 29569387
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ADIPOQ polymorphism rs182052 is associated with clear cell renal cell carcinoma.
    Zhang G; Gu C; Zhu Y; Luo L; Dong D; Wan F; Zhang H; Shi G; Sun L; Ye D
    Cancer Sci; 2015 Jun; 106(6):687-691. PubMed ID: 25827778
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Insulin-like growth factor binding protein-3 (IGFBP-3) gene variants are associated with renal cell carcinoma.
    Safarinejad MR
    BJU Int; 2011 Sep; 108(5):762-70. PubMed ID: 21314884
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Polymorphism rs4787951 in IL-4R contributes to the increased risk of renal cell carcinoma in a Chinese population.
    Lin Y; Yuan Q; Qian F; Qin C; Cao Q; Wang M; Chu H; Zhang Z
    Gene; 2019 Feb; 685():242-247. PubMed ID: 30472377
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of functional polymorphisms of cyclooxygenase 2 in renal cell carcinoma.
    Chang WS; Liao CH; Miao CE; Wu HC; Hou LL; Hsiao CL; Ji HX; Tsai CW; Bau DT
    Anticancer Res; 2014 Oct; 34(10):5481-6. PubMed ID: 25275044
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Germline genetic variants in somatically significantly mutated genes in tumors are associated with renal cell carcinoma risk and outcome.
    Shu X; Gu J; Huang M; Tannir NM; Matin SF; Karam JA; Wood CG; Wu X; Ye Y
    Carcinogenesis; 2018 May; 39(6):752-757. PubMed ID: 29635281
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CTLA-4 and CD28 genes' polymorphisms and renal cell carcinoma susceptibility in the Polish population--a prospective study.
    Tupikowski K; Partyka A; Kolodziej A; Dembowski J; Debinski P; Halon A; Zdrojowy R; Frydecka I; Karabon L
    Tissue Antigens; 2015 Nov; 86(5):353-61. PubMed ID: 26403483
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combined Genotype Analyses of Precursor miRNA196a2 and 499a Variants with Hepatic and Renal Cancer Susceptibility a Preliminary Study.
    Toraih EA; Fawz MS; Elgazzaz MG; Hussein MH; Shehata RH; Daoud HG
    Asian Pac J Cancer Prev; 2016; 17(7):3369-75. PubMed ID: 27509977
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Concomitance of Polymorphisms in Glutathione Transferase Omega Genes Is Associated with Risk of Clear Cell Renal Cell Carcinoma.
    Radic TM; Coric VM; Pljesa-Ercegovac MS; Basta-Jovanovic GM; Radojevic-Skodric SM; Dragicevic DP; Matic MG; Bogdanovic LM; Dzamic ZM; Simic TP; Savic-Radojevic AR
    Tohoku J Exp Med; 2018 Sep; 246(1):35-44. PubMed ID: 30224590
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.